Syntheses of benzoquinolizidine and benzoindolizidine derivatives as anti-amnesic agents

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 8, 1999, Pages 1637-1646

  Zhao, Shikai ^a   Totleben, Michael J ^a   Freeman, Jeremiah P ^a   Bacon, C L ^b   Fox, G B ^b   O'Driscoll, E ^b   Foley, A G ^b   Kelly, J ^b   Farrell, U ^b   Regan, Ciaran ^b   Mizsak, Stephen A ^c   Szmuszkovicz, Jacob ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; INDOLIZIDINE DERIVATIVE; QUINOLIZIDINE DERIVATIVE; TACRINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SHORT SURVEY;

EID: 0032811382     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00078-4     Document Type: Article

References (30)

1. (a) Cacabelos, R.; Nordberg, A.; Caamaño, J.; Franco-Maside, A.; Fernandez-Novoa, L.; Gomez, M. J.; Alvarez, X. A.; Takedas, M.; Prous, J., Jr.; Nishimura, T.; Winblad, B. Drugs of Today 1994, 30, 295.
2. (b) Allain, H., Bentue-Ferrer, D.; Belliard, S.; Derouesne, C. Prog. Med. Chem. 1997, 34, 46.
3. (c) Crimson, M. L. Ann. Pharmacother. 1994, 28, 744.
4. (d) Hershenson, F. M.; Moos, W. H. J. Med. Chem. 1986, 29, 1125.
5. Hershenson, F. M. In New Leads and Targets in Drug Research, Alfred Benzon Symposium 33; Krogsgaard-Larsen, P.; Brøgger, S.; Kofod, H., Eds.; Munksgaard: Copenhagen, 1992; p 354.
6. (a) Inoue, A.; Kawai, T.; Wakita, M.; Iimura, Y.; Sugimoto, H.; Kawakami, Y. J. Med. Chem. 1996, 39, 4460.
7. (b) Kawakami, Y.; Inoue, A.; Kawai, T.; Wakita, M.; Sugimoto, H.; Hopfinger, A. J. Bioorg. Med. Chem. 1996, 4, 1429.
8. (c) Heydorn, W. E. Exp. Opin. Invest. Drugs 1997, 6, 1527.
9. Drugs Future 1994, 19, 656; 1996, 21, 766.
10. Drugs Future 1994, 19, 656; 1996, 21, 766.
11. Manning, F. C. American Family Physician 1994, 50, 819.
12. (a) Osterrieder, W. Br. J. Pharmac. 1987, 92, 521; Edwards, G.; Weston, E. H. In Receptor Data for Biological Experiments; Ellis Horwood: New York, 1991; p 194.
13. (a) Osterrieder, W. Br. J. Pharmac. 1987, 92, 521; Edwards, G.; Weston, E. H. In Receptor Data for Biological Experiments; Ellis Horwood: New York, 1991; p 194.
14. (b) Evans, J. M.; Hamilton, T. C.; Longman, S. D.; Stemp, G.; Eds.; Potassium Channels and their Modulators: From Synthesis to Clinical Experience; Taylor and Francis, 1996.
15. (c) Glover, W. E. Gen. Pharmacol. 1982, 13, 259.
16. (d) Drugs Future 1995, 20, 142.
17. O'Neill, P. M.; Bray, P. G.; Hawley, S. R.; Ward, S. A.; Park, B. K. Pharmacol. Ther. 1998, 77, 29.
18. Drugs Future 1991, 16, 33; 1994, 19, 343.
19. Drugs Future 1991, 16, 33; 1994, 19, 343.
20. Gonzalez, Trigo G.; Alvarez-Builla, J. An Quim Ser C 1980, 76, 12: CA, 94, 139584c.
21. Rausser, R.; Weber, L.; Hershberg, E. B.; Oliveto, E. P. J. Org. Chem. 1966, 31, 1342.
22. Bolton, R.; Danks, T. N.; Paul, J. M. Tetrahedron Lett. 1994, 35, 3411.
23. Chaki, H.; Yamabe, H.; Sugano, M.; Morita, S.; Bessho, T.; Tabata, R.; Saito, K.-I.; Egawa, M.; Tobe, A.; Morinaka, Y. Bioorg. Med. Chem. Lett. 1995, 5, 1489.
24. Chaki, H.; Yamabe, H.; Sugano, M.; Morita, S.; Bessho, T.; Tabata, R.; Saito, K.-I; Egawa, M.; Tobe, A.; Morinaka, Y. Bioorg Med. Chem. Lett. 1995, 5, 1495.
25. (a) Rigo, B.; Kolocouris, N. J. Heterocyclic Chem. 1983, 51, 893.
26. (b) Martin, L. L.; Scott, S. J.; Agnew, M. N.; Setescak, L. L. J. Org. Chem. 1986, 51, 3697.
27. Lowry, O. H.; Rosenbrough, N. J.; Farr, A. L.; Randall, R. J. J. Biol. Chem. 1995, 193, 265.
28. Ellman, G. L.; Courtney, K. D.; Andres, V., Jr.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88.
29. Whittaker, M. Methods of Enzyme Analysis 1984, 4, 52.
30. Fox, G. B.; O'Connell, A. W.; Murphy, K. J.; Regan, C. M. J. Neurochem. 1995, 65, 2796.